VEGFC and metabolic disease: In this study, we discovered that the hyperphosphatemia, one of the common metabolic disorders in pre‐dialysis CKD patients, impeded the construction of mouse AVF lymphatic network by producing additional sVEGFR3, the decoy receptor for VEGF‐C, and blunted VEGF‐C responsiveness in LECs.